Aprea expands cancer trial sites and plans Q4 2026 data update
Go back to Aprea expands cancer trial sites and plans Q4 2026 data update| Aperture Health, Inc. (NASDAQ: APRE) | Delayed: 0.67 -0.02 (2.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.69 | 52 Week High | $0.08 | |||
| Open | $0.71 | 52 Week Low | $0.00 | |||
| Day High | $0.71 | P/E | N/A | |||
| Day Low | $0.67 | EPS | $0.00 | |||
| Volume | 10,489 | |||||
